News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
In the Media News & Stories
In the Media, Staff/Faculty Update
Eberlein named President-Elect of American College of Surgeons
Timothy J. Eberlein, MD, FACS, director of Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, has been elected president-elect of the American College of Surgeons (ACS). The three-year commitment includes one-year terms each as president-elect, president and immediate past-president. Eberlein began his term as president-elect after ACS’s annual meeting this month in Chicago. With […]
Clinical, In the Media, Staff/Faculty Update
Dehdashti honored by Radiological Society
Award recognizes her career contributions in research Physician-scientist Farrokh Dehdashti, MD, the Drs. Barry A. and Marilyn J. Siegel Professor of Radiology and senior vice-chair and director of the Division of Nuclear Medicine at WashU Medicine, is being recognized by the Radiological Society of North America for advancing the radiologic sciences throughout her career in research. […]
Clinical, In the Media, Research
1,000th patient treated at Siteman with AI-enabled radiation therapy system
Combining artificial intelligence (AI) with advanced imaging, the technology supports more precise, personalized daily treatments by WashU Medicine physicians Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine has treated its 1,000th patient using state-of-the art radiation therapy technology that allows physicians to update a patient’s treatment plan on each day of treatment. Called adaptive […]
In the Media, Research
Working together, cells extend their senses
New research from Amit Pathak’s lab has implications for tracking cancer The story of the princess and the pea evokes an image of a highly sensitive royal young woman so refined, she can sense a pea under a stack of mattresses. When it comes to human biology, it also takes an abnormal individual to sense […]
In the Media, Staff/Faculty Update
Bennett named Evens Professor of Women’s Health
WashU Medicine breast cancer imaging specialist Debbie L. Bennett, MD, chief of breast imaging at Mallinckrodt Institute of Radiology (MIR), was installed Aug. 14 as the Ronald and Hanna Evens Endowed Chair in Women’s Health at Barnes-Jewish Hospital. Bennett oversees screening and diagnostic mammography services at Siteman Cancer Center, based at WashU Medicine and Barnes-Jewish […]
In the Media, Research
Siteman investment program awards $2.42 million for cancer research
Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine is pleased to announce funding for 12 new projects, including four clinical trials. Through this research, investigators aim to improve the understanding of tumor formation and growth, develop safer, more effective therapies, and explore new cancer screening strategies. The projects will benefit from $2.42 million in […]
In the Media, Research
AI-Based Breast Cancer Risk Technology Receives FDA Breakthrough Device Designation
Software developed at WashU Medicine on accelerated path to approval A new technology that harnesses AI to analyze mammograms and improve the accuracy of predicting a woman’s personalized five-year risk of developing breast cancer has received Breakthrough Device designation from the Food and Drug Administration (FDA). Developed by researchers at Washington University School of Medicine […]
In the Media, Research
Genetic study suggests ways to catch blood cancer earlier
New understanding of how mutations interact could pave way for early detection, prevention strategies As we age, our cells replicate, and the DNA in these cells can acquire mistakes — or mutations — every time the sequence is copied. Most newly acquired mutations are harmless, but some can tip the balance toward cancer development later […]
In the Media
FDA approves standard-changing therapy trialed at Siteman
Immunotherapy Improves Survival of Patients with Locally Advanced Head and Neck Cancer The Food and Drug Administration (FDA) has approved a new standard of care for certain locally advanced head and neck cancers — the first change in standard-of-care therapy for affected patients in more than two decades. This follows the promising results of clinical […]
In the Media, Staff/Faculty Update
Thaker named Chief of Gynecologic Oncology
Nationally recognized clinical trials expert, also known for outstanding patient care Premal H. Thaker, MD, MS, a physician-scientist recognized for her expertise in conducting clinical trials, authoring numerous medical and scientific publications and outstanding patient care, has been named chief of the Division of Gynecologic Oncology at WashU Medicine. In this role, she oversees a […]